Archive for the ‘Lyme’ Category

A Blind Spot on Autism

https://www.lymedisease.org/autism-infectious%E2%80%91disease-lens/

Looking at autism through an infectious‑disease lens

The following excerpt comes from A Blind Spot on Autism. The book is co‑authored by Debbie Kimberg, a mother and advocate whose writing for LymeDisease.org has chronicled her son’s improvement after treatment for vector‑borne infections including Borrelia, Bartonella, and Babesia. She partners with Dr. Ed Breitschwerdt, one of the world’s leading Bartonella researchers. Together, they blend lived experience and scientific expertise to explore biological patterns they believe have been overlooked in autism research.

By Debbie Kimberg and Dr. Ed Breitschwerdt

Article Excerpts:

From the moment we step into a doctor’s office, we’re taught to think of health problems as separate boxes. A child’s learning issues go to a specialist for educational testing. A sibling’s anxiety is treated by a mental health professional. A parent’s autoimmune disease is managed by a rheumatologist. A grandparent’s memory loss goes to neurology.

Medicine is organized this way.

This book brings together two perspectives rarely combined: the lived experience of navigating these patterns as a parent and patient advocate, and the decades of research from one of the world’s leading infectious disease experts. Our goal is not to dismiss the work already done on autism, but to attempt to connect the dots between existing research that has remained scattered across a thousand scientific papers, often among different fields of study. When viewed together, these studies point toward a hypothesis that could explain both the near-exponential rise in autism cases and the convoluted web of health problems in so many families.

This is not the first time medicine has been blindsided by an invisible infectious cause. History is full of examples where an infectious trigger hid in plain sight for decades before science caught up. Syphilis was once thought to be a mysterious neurological illness, ulcers were blamed on stress, and HIV was first recognized only by its complications. Each time, the truth emerged slowly, in pieces, and often against the resistance of the medical establishment.

….Bartonella species may represent one of the most stealth and dangerous pathogens seen in generations, pathogens that have been allowed to spread silently, reshaping the health of millions without recognition.  (See link for article & ordering info)

_____________

**Comment**

Sadly, autism is only one such illness with an infectious connection.  In this study, it was found that 92% of pediatric bip0lar disorder had tick-borne infections exposure.  PANS is connected with Lyme and mycoplasma.

For more:

 

Lyme Community Loses Three Leaders and Friends

Lyme Community Loses Three Friends

The Lyme community has recently lost three trail blazers: Dr. Alan B. MacDonald (pathologist), Dr. Alex Shikhman (rheumatologist & advocate), and Dr. Charles Crist (physician & advocate).

RIP – you will all be greatly missed.

 

How Ticks Became Bioweapons

https://spectator.com/article/how-ticks-became-bioweapons/

How ticks became bioweapons

By Kris Newby

1/19/26

On December 18 last year, Donald Trump signed into law an order to “review and report on biological weapons experiments on and in relation to ticks [and] tick-borne diseases.” The investigation is long overdue but even so, the facts it uncovers will come as a shock to many. A growing body of evidence shows that during the Cold War ticks were tinkered with and used as delivery mechanisms for biological warfare agents. And these weaponized ticks may have been released both intentionally and unintentionally on an unsuspecting public by the US military.

Ticks and the diseases they transmit (such as Lyme) pose a growing threat to Americans, the military and to agriculture. Record numbers of tick bites have been reported in New York (in 2024), Maine (in 2024), and Wisconsin (in 2023). The Centers for Disease Control and Prevention estimates approximately 500,000 new cases of Lyme disease annually. About one-third of patients do not respond to recommended treatment protocols.

Bioweapons specialists infected ticks with pathogens to cause disabilityand death to potential enemies

If these microbes have been genetically altered, we need to know. If the military harmed civilians through irresponsible experiments, the government has an obligation to acknowledge and remedy those harms. And if the original outbreak near Lyme, Connecticut, in the 1970s resulted from a hostile foreign act, future biosecurity protections must be strengthened. Knowing the root cause of an epidemic is vital in developing treatment strategies, containing the outbreaks and preventing future ones. And then there’s the issue of what else ticks may be carrying. (See link for article)

____________

**Comment**

Sadly, Newby propitiates the ‘climate change’ myth regarding tick and disease proliferation.  This is a key point as there are only so many research dollars which are highly sought after.  By perpetuating a myth, we purposely limit those funds even further by funding research that has already been proven false.

The article does, however, go through the chronology of tick research as well as the fact researchers dropped these infected ticks on unsuspecting populations (Operation Mongoose, etc.)

Important excerpt:

….documents obtained by the CIA during the Cold War showed that the Soviets were conducting bioweapons-related experiments on ticks, including exploring ways to get ticks to reproduce more rapidly, selectively crossbreeding tick species so they could carry disease agents that caused tick-borne encephalitis and dropping infected ticks from aircraft and balloons. Intelligence reports on “entomological warfare” stoked fear and paranoia in the Pentagon, and the Cold War bug-borne weapons race began.

For more:

 

Lyme Disease & Health Care Costs

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/

Lyme Disease and Health Care Costs

(Deny, deny, deny those claims! You might want to read this.)

Carl TuttleHudson, NH, United States

Jan 18, 2026

Letter to the editor of JAMA Network Open:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “eli-perencevich@uiowa.edu” <eli-perencevich@uiowa.edu>, “eli.perencevich@jamanetwork.org” <eli.perencevich@jamanetwork.org>
Cc: “sfihn@uw.edu” <sfihn@uw.edu>, “jamanetworkopen@jamanetwork.org” <jamanetworkopen@jamanetwork.org>, “stephan.fihn@jamanetwork.org” <stephan.fihn@jamanetwork.org>
Date: 01/15/2026 3:16 PM EST
Subject: Lyme Disease and Health Care Costs; JAMA Network Open

JAMA Network Open

Lyme Disease and Health Care Costs
John J. Halperin, MD   January 14, 2026
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843880

Conclusions and Relevance  

“In this retrospective cohort study, LD presented a large financial burden to the health care system and patients, especially for those with disseminated disease. These findings highlight the need for effective preventive measures to reduce costs for patients and the health care system.”

Eli N. Perencevich, MD, MS
Editor in Chief, JAMA Network Open

Dear Dr. Perencevich,

Halperin’s publication just validated what the plaintiffs were claiming from the TORREY v. IDSA racketeering lawsuit; it became too expensive to treat “disseminated disease” (chronic Lyme) so insurance companies were denying claims for treatment beyond the one-size-fits-all IDSA treatment guideline. It should be no surprise that all eight insurance companies immediately settled out of court.

TORREY v. IDSA court document
https://www.courthousenews.com/wp-content/uploads/2017/11/LymeDisease.pdf

This refusal to reimburse has played a pivotal role in the high rates of suicide within the Lyme disease community.

1. Suicide and Lyme and associated diseases
https://pmc.ncbi.nlm.nih.gov/articles/PMC5481283/

2. TOUCHED BY LYME: The thorny question of (no) insurance coverage for Lyme
https://www.lymedisease.org/touched-by-lyme-the-thorny-question-of-no-insurance-coverage-for-lyme

So now we’re calling it “disseminated disease?”  Lyme disease is a systemic infectious disease; is there localized syphilis or localized leptospirosis?

Questions to Google’s Gemini AI:

1. Does a chronic relapsing seronegative disease fit the vaccine model?

AI Response:

A chronic, relapsing, seronegative disease does not fit the traditional vaccine model, which is primarily designed to prevent initial infections. The characteristics you describe present significant scientific and commercial challenges for vaccine developers.

2. Since you agreed that a chronic, relapsing, seronegative disease does not fit the traditional vaccine model, this in and of itself would be the motivation to conceal any and all evidence of persistent infection wouldn’t you agree? This so-called debate is not a debate at all and deserves a criminal investigation. Who would be a suitable candidate to approach for a legal case?

AI Response: 

Allegations of medical fraud are typically handled as civil matters, but they can become criminal if there is evidence of gross negligence, recklessness, or intent to deceive, especially for financial gain.

Dr. Perencevich,

I want to make this crystal clear… Suppressing evidence of antibiotic resistance is not collaboration; it is collusion.

1. Peer-Reviewed Evidence of Persistence of Lyme Disease Spirochete
https://drive.google.com/file/d/1S7ynlfLzmNCjKpPHQuVsa0-pmG-7nf23/view

The following is a list of over 700 peer-reviewed articles that support the evidence of persistence of Lyme and other tick-borne diseases. It is organized into different categories—general, neuropsychiatric, dementia and congenital transmission.

2. Seronegativity in Lyme borreliosis and Other Spirochetal Infections 16 September 2003
https://www.dropbox.com/scl/fi/ycqvn5swemanpjau3le2y/Seronegativity.pdf?rlkey=70bkain5zukjadnyeksvmsc96&dl=0

“If false results are to be feared, it is the false negative result”

3. Congenital Transmission of Lyme
https://www.dropbox.com/scl/fi/ybo7c29xr2rjvtpxjh6gd/Congenital-Transmission-of-Lyme.pdf?rlkey=4p1u28pffoe7lofhvxgiowpxw&dl=0

I have spent the last fifteen years exposing the Lyme disease false public health narrative and have been published in the Lancet Infectious DiseasesThe BMJArthritis and Rheumatology and JAMA. I can say with absolute certainty that it was the rush to create a vaccine that led to the deliberate mishandling of the disease. And here we have a publication funded by the next Lyme vaccine manufacturer and one of the defendants named in the racketeering lawsuit. I rest my case.

Respectfully Submitted,

Carl Tuttle
Independent Researcher
Hudson, NH

Letter to the Editor of the BMJ published June 2020 
https://www.bmj.com/content/369/bmj.m1041/rr-1

Cc: Stephan D. Fihn, MD, MPH
Executive Deputy Editor

_______________

For more:

Treating Lyme & TBDs on a Budget With Herbs

Webinar: Treating Lyme and Tick-Borne Diseases on a Budget

Date: Wednesday, March 18

Time: 6:00-7:00 PM ET

Presenter: Teresa Holler, MS, PA-C, FMAPS

Free to ILADS members/$49 for non-members

Register Here

Description:

Teresa will discuss a simple, effective, and well researched approach to utilizing herbals in the management of Lyme disease, bartonella, and babesia. Participants will leave the presentation with treatment options that are easy to implement.

Upon completion of Teresa’s presentation, participants will be aware of the following:

• Unique signs and symptoms to help differentiate between borrelia, bartonella, and babesia by history and physical exam
• What causes microbial persistence and how to address these difficulties
• Awareness of clinical studies comparing several antibiotic protocols to herbal products
• Review the properties of the most efficacious herbs for the treatment of Lyme disease, bartonella and babesia.

This webinar will be recorded and sent to all registered attendees.

Available through ILADS

To access the FREE 1.5 hour ILADS December webinar titled “At the Frontlines of Chronic Illness: A Conversation with ILADS Experts”, go here.

It features ILADS panelists:

  • Chris Winfrey, MD
  • Melanie Stein, ND
  • Nicole Bell (Galaxy Diagnostics)
  • Tania Dempsey, MD responding to patient questions